ORIGINAL ARTICLE |
|
Year : 2018 | Volume
: 35
| Issue : 3 | Page : 282-286 |
|
Noninvasive predictors of hepatic fibrosis in patients with chronic hepatitis C virus in comparison with liver biopsy
Ayman N Menessy1, Nancy A Ahmed1, Nagwa I Abdallah2, Salah S Arif3
1 Department of Internal Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt 2 Department of Mansoura Insurance Hospital, Mansoura, Egypt 3 Department of Clinical Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
Correspondence Address:
Dr. Nancy A Ahmed Department of Internal Medicine, Mansoura Egypt
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/bmfj.bmfj_132_17
|
|
Background Liver fibrosis is the main predictor of the progression of chronic hepatitis C, and its assessment by liver biopsy can help plan therapy. However, biopsy is an invasive procedure with occasional complications and poor patient acceptance.
Aim The aim of this work was to compare noninvasive and invasive methods for evaluation of fibrosis in patients with chronic hepatitis C.
Patients and methods This cross-sectional study was carried out at the Liver Unit of Mansoura University Hospital and Mansoura Health Insurance Hospital. The study was conducted on 100 patients with chronic active hepatitis. Biochemical and virological studies were performed in addition to abdominal ultrasonography and liver biopsy in all patients. Moreover, analyses of serum fibronectin (FN), AST-to-platelet ratio index (APRI), and alanine aminotransferase/aspartate aminotransferase (AST/ALT) ratio were performed.
Results We found that FN has the highest sensitivity and specificity, and the independent variables related to fibrosis were FN, APRI, and AST/ALT ratio.
Conclusion The biochemical tests including APRI, AST/ALT ratio, and particularly FN could be valuable noninvasive predictors for assessment of liver fibrosis in patients with chronic hepatitis C infection.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|